BioMarin Pharma (BMRN) Reports In-Line Q4 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St futures muted as investors monitor US-Iran negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
BioMarin Announces Fourth Quarter and Full Year 2021 Financial Results and Corporate Updates
February 23, 2022 4:03 PM ESTSAN RAFAEL, Calif., Feb. 23, 2022 /PRNewswire/ --
Financial Highlights (in millions of U.S. dollars, except per share data, unaudited)Â Â Â Â
Three Months Ended December 31,
Twelve Months Ended December 31,
2021
2020
% Change
... More